Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa P Lokugamage

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Current Opinion in Biomedical Engineering|April 2, 2019
Testing thousands of nanoparticles <i>in vivo</i> using DNA barcodesMelissa P Lokugamage, Cory D Sago, James E Dahlman
Advanced Materials (Deerfield Beach, Fla.)|August 30, 2019
Constrained Nanoparticles Deliver siRNA and sgRNA to T Cells In Vivo without Targeting LigandsMelissa P Lokugamage, Cory D Sago, Zubao Gan, et al.
Advanced Healthcare Materials|March 4, 2021
Therapeutic RNA Delivery for COVID and Other DiseasesCurtis Dobrowolski, Kalina Paunovska, Marine Z C Hatit, et al.
Cellular and Molecular Bioengineering|November 14, 2019
Cell Subtypes Within the Liver Microenvironment Differentially Interact with Lipid NanoparticlesCory D Sago, Brandon R Krupczak, Melissa P Lokugamage, et al.
ACS Synthetic Biology|February 1, 2017
Selective Inactivation of Functional RNAs by Ribozyme-Catalyzed Covalent ModificationRaghav R Poudyal, Malak Benslimane, Melissa P Lokugamage, et al.
Journal of the American Chemical Society|November 6, 2018
Nanoparticles That Deliver RNA to Bone Marrow Identified by in Vivo Directed EvolutionCory D Sago, Melissa P Lokugamage, Fatima Z Islam, et al.
Bioengineering & Translational Medicine|March 24, 2021
Nanoparticles containing constrained phospholipids deliver mRNA to liver immune cells in vivo without targeting ligandsZubao Gan, Melissa P Lokugamage, Marine Z C Hatit, et al.
Nucleic Acids Research|February 10, 2017
Nucleobase modification by an RNA enzymeRaghav R Poudyal, Phuong D M Nguyen, Melissa P Lokugamage, et al.
Nano Letters|September 15, 2018
Modifying a Commonly Expressed Endocytic Receptor Retargets Nanoparticles in VivoCory D Sago, Melissa P Lokugamage, Gwyneth N Lando, et al.
Advanced Materials (Deerfield Beach, Fla.)|November 20, 2019
Mild Innate Immune Activation Overrides Efficient Nanoparticle-Mediated RNA DeliveryMelissa P Lokugamage, Zubao Gan, Chiara Zurla, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Opinion in Biomedical Engineering|April 2, 2019
Testing thousands of nanoparticles <i>in vivo</i> using DNA barcodesMelissa P Lokugamage, Cory D Sago, James E Dahlman
Advanced Materials (Deerfield Beach, Fla.)|August 30, 2019
Constrained Nanoparticles Deliver siRNA and sgRNA to T Cells In Vivo without Targeting LigandsMelissa P Lokugamage, Cory D Sago, Zubao Gan, et al.
Advanced Healthcare Materials|March 4, 2021
Therapeutic RNA Delivery for COVID and Other DiseasesCurtis Dobrowolski, Kalina Paunovska, Marine Z C Hatit, et al.
Cellular and Molecular Bioengineering|November 14, 2019
Cell Subtypes Within the Liver Microenvironment Differentially Interact with Lipid NanoparticlesCory D Sago, Brandon R Krupczak, Melissa P Lokugamage, et al.
ACS Synthetic Biology|February 1, 2017
Selective Inactivation of Functional RNAs by Ribozyme-Catalyzed Covalent ModificationRaghav R Poudyal, Malak Benslimane, Melissa P Lokugamage, et al.
Journal of the American Chemical Society|November 6, 2018
Nanoparticles That Deliver RNA to Bone Marrow Identified by in Vivo Directed EvolutionCory D Sago, Melissa P Lokugamage, Fatima Z Islam, et al.
Bioengineering & Translational Medicine|March 24, 2021
Nanoparticles containing constrained phospholipids deliver mRNA to liver immune cells in vivo without targeting ligandsZubao Gan, Melissa P Lokugamage, Marine Z C Hatit, et al.
Nucleic Acids Research|February 10, 2017
Nucleobase modification by an RNA enzymeRaghav R Poudyal, Phuong D M Nguyen, Melissa P Lokugamage, et al.
Nano Letters|September 15, 2018
Modifying a Commonly Expressed Endocytic Receptor Retargets Nanoparticles in VivoCory D Sago, Melissa P Lokugamage, Gwyneth N Lando, et al.
Advanced Materials (Deerfield Beach, Fla.)|November 20, 2019
Mild Innate Immune Activation Overrides Efficient Nanoparticle-Mediated RNA DeliveryMelissa P Lokugamage, Zubao Gan, Chiara Zurla, et al.
Pageof 3